Skip to main navigation Skip to search Skip to main content

Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

The clinical uses of oral isotretinoin (13-cis-retinoic acid) are many. They include treatment of acneiform eruptions, diseases of cornification, inflammatory disorders, and neoplastic processes. Isotretinoin has shown greater efficacy in the chemoprevention of squamous cell carcinoma, rather than in the treatment. High-dose isotretinoin has mainly been utilized in those patients at high-risk for multiple new skin cancers where the risk of morbidity from side effects is overshadowed by the benefit to the patient.

Original languageEnglish
Pages (from-to)498-502
Number of pages5
JournalJournal of Drugs in Dermatology
Volume3
Issue number5
StatePublished - 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.'. Together they form a unique fingerprint.

Cite this